A possible new cancer cure

[Guest guest]

Below article is from Zenit (A vatican news) about a possible new cancer

drug.Even they avoided US due to its pharmaceutical companies " greed " .

 

Melly

================================

 

ROME NOTES

 

-------------------

 

A Believe-It-or-Not Cancer Drug

 

CellAdam Is Successful, Natural, Ethical Product

 

By Edward Pentin

ROME, JAN. 22, 2009 (Zenit.org).- Imagine a medicine that has a staggering 75%

success rate in treating cancer, and yet is a natural and ethical product, owned

by a nonprofit company headed by devout Catholics.

 

Too good to be true? That's what I thought. The medical world is not short of

bogus cancer " cures. " Treatment for the disease is a multi-billion dollar

industry that has led to questionable or unproven methods springing up

throughout the world.

 

Yet this little-known product, which works by rebuilding the body's own adult

stem cells and destroying tumour cells, already has a 25-year track record as a

highly effective cancer treatment. Called CellAdam, it is most effective in

preventing the early stages of cancer. But it also impedes the malignant

process, and has an analgesic effect in the hopeless stage of an advanced

tumour. Because of its natural composition, it has none of the hallucinogenic

effects you get with morphine. The ingredients simply include a fatty acid

complex extracted from soy and sunflower.

 

" This is a totally unusual and huge breakthrough, " says Dr. Thomas Janossy,

president of Biostemworld, the company producing the drug internationally. " In

the next two to three years, it will become the first anti-cancer prescription

drug in the world that is nature-based. "

 

So why has hardly anyone heard of it? According to Biostemworld, the reason is

because it was developed in Hungary during the country's Communist era. CellAdam

was discovered, by chance, by Adam Kovacs, a Christian Hungarian researcher, who

put his whole life into finding a cure for cancer.

 

Imre Beke, Biostemworld's chairman, calls it a " diamond in disguise " because of

the numerous obstacles that have prevented this drug from reaching a wider

market.

 

The first hindrance has been the Hungarian language. " As the researchers of this

drug only speak Hungarian, it's not been widely published in international media

and so nobody really knows about it, " says Beke. Then there was the country's

Communist past and personal rivalries that remained even after the fall of the

Berlin Wall.

 

Breaking out

 

" Envy, old skirmishes and conflicts, pharmaceutical companies worried about

losing their market share in the cancer business -- which is huge -- all played

a part, " Beke explains. Moreover, Kovacs was a medical assistant and not part of

the Hungarian medical establishment. The country's medical professionals,

perhaps envious of his discovery, always blocked the drug from wider

distribution.

 

" Now " , says Beke, " we're really breaking out. "

 

I caught up with Beke, Janossy and their public relations officer, Maria

Dalgarno, while they were visiting Rome earlier this month. They were staying,

it should be noted, not at the Hilton, but at the modest Generalate of the Sons

of the Immaculate Conception. Their purpose was to meet members of a Catholic

hospital run by a religious order whose charism is to help the sick.

 

The company wants the order, which has 400 cancer researchers in Italy, to carry

out human and animal research on the medicine. They wouldn't name the order as

negotiations are still continuing, but the hope is it will carry out more

quantitative analysis to make the alternative therapy more viable. It can then

also be formally classed as a drug, have more credibility and be distributed

more widely.

 

The Catholic factor in this is significant. Rather than make large profits from

CellAdam, the company wants to plough all revenues made from the drug back into

research, or to help Church missions. " We had a lot of opportunities to sit down

with many medical research centers, " says Janossy. " But the inventor, who is a

Christian, was looking for people who spoke Hungarian, were Christian-Catholic,

and who had scientific and business backgrounds. Somehow we got together. "

 

Janossy says the company steered clear of the United States because of its

heavily profit-oriented pharmaceutical industry, and instead looked toward this

Italian Catholic hospital. " Their whole approach to healing is so different, "

Janossy says. " The president is a priest who's not picking up a salary. All the

profit goes back to research or is sent to the missions. That is extremely

unique. So we said, 'OK we will share this product and the potential it has.' "

 

Nonprofit

 

Once any cancer drug hits the market, it can generate revenues of hundreds of

millions of dollars. Biostemworld is expecting CellAdam will generate over a

billion dollars once it becomes fully viable in about two to three years. " It's

huge, " says Janossy, " but we want the profit to be shared or managed by a

Catholic interest where the hope is that the profit will help the people in

need. It's a very unusual approach. "

 

So what evidence is there that this drug really works? Apparently, there is no

shortage of testimonies, in addition to the company's claim that it has a 75%

success rate. There is a bus driver in Hamilton, Canada, who has just found out

that after taking CellAdam for less than a month, a 5-centimeter tumour has been

reduced to the size of pea and now he doesn't have to worry about having

chemotherapy.

 

There is the case of a woman with lung cancer -- the hardest kind to treat --

which had become so bad that she had gone home to die. " She started to take

CellAdam and within two months she was practically clear, " says Janossy.

 

" Constantly, every couple of days, there are these dramatic cases. " Janossy says

an ongoing 10-year study in Hungary is currently focusing on two groups of

cancer sufferers. One group, who all went through chemotherapy, have since died,

but those who have been taking CellAdam are still alive.

 

CellAdam works by breaking down a shield that is preventing cancer cells from

communicating with the body's natural immune system, allowing it to kill the

cancer cells. " It is putting back your immune system into balance, " explains

Beke, " assisting your immune system to cure the cancer, enhancing your own

system to be natural and letting a natural process take over a sick body. "

Certain cells react better than others to the drug, such as breast, lung and

large intestinal cancer cells, melanoma malignum and certain types of obstetric

tumours. But even large tumours can be blocked by CellAdam, claims Biostemworld.

 

Prevention

 

It's best track record, however, is as a cancer prevention therapy. When used as

a dietary supplement, it works by building up the body's adult stem cell count.

Stem cells can decrease by as much as 80% in the course of a lifetime, leading

to signs of ageing, a weakened immune system, and diseases such as cancer. With

CellAdam and its other nature-based drugs, Biostemworld claims it can restore

that count by as much as 75%, exceeding a similar product in California by 50%.

Not only do they prevent cancer, but other diseases too.

 

Furthermore, Biostemworld argues its products are without the dangers associated

with synthetic drugs because they are less toxic. Janossy says pharmaceutical

companies prefer synthetic drugs because they are easier to patent and so make

more money. But he adds that synthetic drugs tend to mimic what is already

available in natural drugs, some of which have been used in countries such as

China for over 4,000 years.

 

But perhaps the most persuasive proof of this drug's effectiveness is the belief

among those running Biostemworld that this discovery is Providential. Global

cancer deaths are expected to rise by 45% by 2030, overtaking cardio-vascular

disease as the biggest cause of death, and putting great strain on health

services and society. " We feel in a lot of ways that Our Lady has really

inspired us, " says Maria Dalgarno who is also a member of the Catholic movement

Focolare. " [Governments] know the system can't manage it -- they've said it.

There's no way they can take care of all those people. "

 

She pointed to the growth of euthanasia, which is gaining popularity in the West

as demand for health care for the elderly increases. " My first thought when this

company was forming was: bingo, this had to come because the medical

establishment is saying: 'What are we going to do with all these old people?' "

 

Dalgarno felt it was " truly God's work, " not only because it could help counter

the push toward euthanasia, but also because their products are less expensive,

less dangerous and more ethical. Embryonic stem cell research plays no part in

this medicine.

 

" We put our work daily under the protection of Our Lady, " says Dalgarno,

" knowing she is guiding our work and the 'mission in the health field' that we

feel called to. "

 

Like the Good News, this does seem too good to be true, but perhaps that just

shows that this drug really does have the Divine hand behind it.

 

More details on CellAdam and Biostemworld's other nature-based disease

prevention products can be found at: http://biostemworld.com/portal/

 

* * *

 

Edward Pentin is a freelance writer living in Rome. He can be